Purpose. The current study aimed to examine the association between head and neck squamous cell carcinoma (HNSCC) and infection with different human papillomavirus virus (HPV) subtypes, including analysis of promoter methylation of several genes (APC, CDKN2A, MGMT, CDH1 and TIMP3) and the correlation with their mRNA expression in tumours and surgical margins.
INTRODUCTION
Almost 540 000 new cases of head and neck squamous cell carcinoma (HNSCC) occur worldwide each year. It is well known that alcohol and cigarettes are the most important HNSCC risk factors, but nonetheless HNSCC is also observed among non-smokers and non-drinkers under the age of 45 years and is attributed to human papillomavirus (HPV) [1] . The frequency of oncogenic HPV in HNSCC cases varies between 5 and 90 %, depending primarily on tumour site, geographical and ethnical differences among study populations, and detection methods. The most common HPV [+] HNSCC is oropharyngeal squamous cell carcinoma (OPSCC), accounting for 60 % of all cases in the United States and >90 % in Scandinavian countries [2] . According to meta-analysis performed by Ndyiaye et al., the global prevalence of HPV in OPSCC is estimated to be 24.2 % (18.7-30.2 %) [3] .
HPV is a small, double-stranded DNA virus belonging to the Papillomaviridae family. Over 200 HPV types have been isolated, and are classified into high-and low-risk groups. Low-risk HPV (subtypes 6, 11, 43, 44) causes benign condylomas whereas high-risk HPV, such as types 16 and 18 , is responsible for pre-malignant squamous cell neoplasia that can lead to cancer [4] . The HPV genome consists of approximately 8000 base pairs and displays a well-preserved general organization. It includes 'early' open reading frames (ORFs, E1-E7), expressed shortly after infection and prior to the onset of DNA replication, and 'late' ORFs (L1-L2) which encode viral capsid proteins. The early gene products are responsible for oncogenic potential, taking part in replication and expression of the virus as well as transformation of the host cell [5] .
In our work we aimed to examine the association between head and neck squamous cell carcinoma and infection by different HPV subtypes. In our previous studies we concentrated on mRNA expression and promoter methylation levels of genes APC, CDKN2A, MGMT, CDH1 and TIMP3 in HNSCC tumour and margin tissue. In this paper, we investigated the association of previously obtained results with HPV infection.
METHODS

Study population
This study was approved by the Institutional Review Board on Medical Ethics of the Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology in Gliwice (No KB/493-15/08 and KB/430-47/13). From all patients we obtained a written informed consent form. We studied 47 patients with a primary tumour and whose clinical characteristics are presented in Table 1 . All tumours collected during surgical operations were classified as oral cavity cancers, including those involving the mandible, floor of the mouth, tongue and cheek. Tumour staging was determined in accordance with the TNM classification [6] . Smoking and alcohol information was obtained from patients' medical history. None of patients had received preoperative radioor chemotherapy. Patient survival rates were 62.00 % in stage >II TNM and 100 % in stages I and II TNM.
DNA extraction
Genomic DNA was extracted from each sample of fresh frozen tumour tissue (20 mg) using the DNeasy Blood & Tissue Kit (Qiagen, USA) according to the manufacturer's instructions, following homogenization of tissues using the FastPrep-24 instrument and Lysing Matrix A tubes (MP Biomedicals, USA). Qualitative and quantitative analysis of the isolated DNA was performed by spectrophotometry using the NanoPhotometer Pearl Spectrophotometer (Implen, Germany) to measure absorbance.
Methylation status and mRNA expression of genes APC, CDKN2A, MGMT, CDH1 and TIMP3 were taken from the results of our previous studies [7] [8] [9] . 
HPV detection
Statistical analysis
Significant differences between the distribution of methylated gene promoters among HPV [+] and [À] groups were tested using Pearson's 2 test. The Shapiro-Wilk test was used to evaluate the distribution of variables. Non-parametric variables are presented as the median with the interquartile range. Non-parametric variables were compared using the Mann-Whitney U-test for unreliable variables, and the Wilcoxon test to compare variables between tumour and margin. Logistic regression modelling was performed to analyse 5-year survival including HPV status, age, grading, sex, and tobacco and alcohol consumption, regarding these as both independent and co-existing factors. P values <0.05 were considered statistically significant. The statistical software STATISTICA 12 for Windows (STATSOFT, USA) was used to perform all analyses. and low-oncogenic HPV types. No differences in tumour grading among these groups were detected. The influence of HPV status on patient survival was insignificant; however, we found that HPV-16 patients were characterized by better survival than HPV-43/44 patients (Table 3) . No interactions between HPV status, smoking or drinking, and patient 5-year survival were noted using logistic regression.
RESULTS
In
In the case of the genes APC, MGMT and CDH1, we found no influence of HPV status on promoter methylation or mRNA expression. The association between CDKN2A methylation and HPV status was insignificant. consideration that carcinogenesis is a multi-step process, apart from gene mutations and expression profile modifications we must consider epigenetic alterations. The most common of these affecting tumour-suppressor genes is methylation of their promotor CpG islands, which results in gene silencing. The level of DNA methyltransferase 1 (DNMT1) is often increased in cancer, and similar alterations are observed in high-risk-type HPV infection, where these are induced by E7 oncoprotein. Chromatin methylation can affect both host cell and viral genomes. Alternative pathways of epigenetic remodelling include interactions of E7 protein with histone acetyltransferases, histone demethylases, complex-associated oncoproteins and miRNA processing-associated proteins [5, [22] [23] [24] [25] .
In our study, we therefore considered promoter methylation of genes APC, CDKN2A, MGMT, CDH1 and TIMP3, as well as their mRNA expression in HPV [+] and HPV [À] oral cancer patients. However, significant results were obtained only in the case of CDKN2A and TIMP3. CDKN2A codes for P16INK4a, a cyclin-dependent kinase that inhibits Rb protein phosphorylation and blocks cell cycle progression at the G1 to S checkpoint [26] . P16 is often inactivated in many cancers, including HNSCC, by deletion, hypermethylation or mutation, and its absence results in a reduced level of the tumour suppressor protein pRb, and consequently in cell proliferation [27, 28] . P16 protein overexpression as assessed by immunohistochemistry (IHC) has become a surrogate marker of oncogenic HPV infection; overexpression occurs because the viral E7 protein inactivates pRb, releasing the CDKN2A gene from negative transcriptional control. Interestingly, overexpression of p16 does not block cell proliferation while pRb level is lowered. [29] . Furthermore, CDKN2A promoter methylation was found to be associated with HPV 16 infection [30] , and some researchers suggest that CDKN2A methylation may serve as a molecular marker for predicting local recurrence in tongue carcinoma [31] The small sample size is a limitation of our research, and therefore further studies are needed to verify this variation in p16 expression.
A significant difference between TIMP3 expression in tumour and margin was found among HPV [À] patients. The TIMP3 gene codes for metalloproteinase inhibitor 3 which, according to its name, inhibits matrix metalloproteinases (MMPs) and as a result slows degradation of the extracellular matrix (ECM) which plays an important role in cancer progression, enhancing tumour growth, infiltration and angiogenesis. Moreover, products of ECM degradation may be responsible for promoting angiogenesis and enhancing tumour proliferation [36] . Furthermore, TIMP3 exerts anti-angiogenic effects by blocking the binding of VEGF to VEGF receptor-2 [37] . Some researchers have reported an association between TIMP3 gene promoter methylation and HPV status in HNSCC, and the association of lower expression of TIMP3 with increased MMP activity leading to more aggressive tumour invasion [38] . TIMP3 gene expression is stimulated by mitogens. Loss of TIMP3 is associated with increased angiogenic and metastatic activity [39] . The balance between TIMPs and MMPs is very important in the early stage of endothelial tube formation during angiogenesis, and therefore decreased inhibition of MMPs leads to both angiogenesis and metastasis [40] . Su et al. reported that lowered TIMP3 levels are inversely correlated with the T-parameter in oral cancer, and loss of TIMP3 protein was associated with more rapid tumour invasion in an animal model of prostate cancer [41, 42] . Shen et al. discovered that TIMP3 can induce G2/M phase arrest, leading to decreased proliferation of hepatocellular [33, 45] . Interestingly, some researchers suggest that lowered expression of the TIMP3 gene resulting from promoter hypermethylation is correlated with enhanced radiotherapy outcome among HNSCC patients [46] . TIMP3 hypermethylation among HPV [+] patients was also reported by Weiss et al. [38] but, in contrast, Lim et al. found no correlation between TIMP3 methylation and HPV status, which is consistent with our results [47] .
In conclusion, we detected HPV infection in 31. 
